Педиатрическая фармакология (Aug 2023)

Clinical guidelines for the management of children with lysosomal acid lipase deficiency

  • Inga V. Anisimova,
  • Marina B. Albegova,
  • Madlena E. Bagaeva,
  • Galina V. Baidakova,
  • Aleksandr A. Baranov,
  • Nato D. Vashakmadze,
  • Elena A. Vishneva,
  • Olga S. Gundobina,
  • Anna V. Degtiareva,
  • Marat V. Ezhov,
  • Maria S. Zharkova,
  • Nataliia V. Zhurkova,
  • Ekaterina Yu. Zaharova,
  • Vladimir T. Ivashkin,
  • Elena A. Kamenets,
  • Sergey I. Kutzev,
  • Alla E. Lavrova,
  • Irina A. Matinian,
  • Svetlana V. Mikhailova,
  • Leyla S. Namazova-Baranova,
  • Irina E. Pashkova,
  • Elena E. Petriaykina,
  • Tatiana M. Pervunina,
  • Nataliia L. Pechatnikova,
  • Nelia S. Pogosian,
  • Svetlana A. Repina,
  • Lilia R. Selimzianova,
  • Tamara A. Skvortsova,
  • Tatiana V. Strokova,
  • Dmitriy M. Subbotin,
  • Andrey N. Surkov,
  • Elena L. Tumanova,
  • Ekaterina G. Tzimbalova

DOI
https://doi.org/10.15690/pf.v20i4.2602
Journal volume & issue
Vol. 20, no. 4
pp. 337 – 354

Abstract

Read online

Lysosomal acid lipase deficiency is s a rare hereditary enzymopathy. The article presents epidemiological data and features of etiopathogenesis of two phenotypic forms of lysosomal acid lipase deficiency — Wolman disease and cholesterol ester storage disease. Special attention has been given to the key issues of differential diagnostic search, clinical guidelines based on the principles of evidence-based medicine have been given.

Keywords